MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors

36Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Background: Proliferation markers widely have been used to diagnose and determine the behaviour and prognosis of benign and malignant tumours. Minichromosome maintenance 3 (MCM3) is a novel proliferation marker. The aim of this study was to evaluate and compare MCM3 with Ki-67 in diagnosis of salivary gland tumours. Materials and Methods: In this retrospective study, immunohistochemical expression of MCM3 and Ki-67 was evaluated in 15 pleomorphic adenomas (PA), 17 mucoepidermoid carcinomas (MEC) and 18 adenoid cystic carcinomas (ADCC) . Labeling indices (LIs) for the two markers were calculated and compared. Results: MCM3 and Ki-67 LIs were significantly higher in MEC and ADCC compared to PA. The LI of MCM3 was significantly higher than that of Ki-67 in MEC and PA. There was no significant difference between the two markers in ADCC. A cut-off point of 8% with 74.3% sensitivity and 93.3% specificity for MCM3 was obtained to discern between benign and malignant tumors. Conclusions: These results suggest that MCM3 might be a useful proliferation marker for differential diagnosis and recognition of clinical behavior of salivary gland tumors.

Cite

CITATION STYLE

APA

Ashkavandi, Z. J., Najvani, A. D., Tadbir, A. A., Pardis, S., Ranjbar, M. A., & Ashraf, M. J. (2013). MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors. Asian Pacific Journal of Cancer Prevention, 14(6), 3479–3482. https://doi.org/10.7314/APJCP.2013.14.6.3479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free